company background image
MED logo

Mediplantex National Pharmaceutical HNX:MED Stock Report

Last Price


Market Cap







22 Jun, 2024


Company Financials

Mediplantex National Pharmaceutical Joint Stock Company

HNX:MED Stock Report

Market Cap: ₫345.0b

Mediplantex National Pharmaceutical Joint Stock Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Mediplantex National Pharmaceutical
Historical stock prices
Current Share Price₫27,800.00
52 Week High₫30,800.00
52 Week Low₫21,100.00
11 Month Change2.96%
3 Month Change21.40%
1 Year Change11.20%
33 Year Change-26.84%
5 Year Changen/a
Change since IPO-43.27%

Recent News & Updates

Recent updates

Shareholder Returns

MEDVN PharmaceuticalsVN Market

Return vs Industry: MED exceeded the VN Pharmaceuticals industry which returned 8.7% over the past year.

Return vs Market: MED matched the VN Market which returned 11.8% over the past year.

Price Volatility

Is MED's price volatile compared to industry and market?
MED volatility
MED Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement4.0%
Market Average Movement4.9%
10% most volatile stocks in VN Market7.5%
10% least volatile stocks in VN Market2.8%

Stable Share Price: MED has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine MED's volatility change over the past year.

About the Company


Mediplantex National Pharmaceutical Joint Stock Company operates as a pharmaceutical company in Vietnam. It provides pharmaceutical products in various categories, including drugs from herbals, analgesics - corticosteroid - anti-inflammatory, antibiotics, anti-malarial and demostasis drugs, gout-diabetes drugs, allergies and osteoarthritis drugs, and acid amin-vitamins and minerals, as well as cerebral circulation, heart, and lung drugs. The company also offers medicinal plant products; and extracting and semi synthetic materials, such as essential oils.

Mediplantex National Pharmaceutical Joint Stock Company Fundamentals Summary

How do Mediplantex National Pharmaceutical's earnings and revenue compare to its market cap?
MED fundamental statistics
Market cap₫345.00b
Earnings (TTM)₫14.70b
Revenue (TTM)₫418.05b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MED income statement (TTM)
Cost of Revenue₫331.31b
Gross Profit₫86.74b
Other Expenses₫72.04b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date


Earnings per share (EPS)1.18k
Gross Margin20.75%
Net Profit Margin3.52%
Debt/Equity Ratio24.3%

How did MED perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.